AbbVie
ABBV
#27
Rank
HK$2.955 T
Marketcap
HK$1,671
Share price
1.78%
Change (1 day)
4.34%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of December 2025 : HK$1.050 Trillion

According to AbbVie's latest financial reports the company's total assets are HK$1.050 Trillion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2025-12-31HK$1.042 T-0.67%
2024-12-31HK$1.049 T-0.26%
2023-12-31HK$1.052 T-2.99%
2022-12-31HK$1.084 T-5.08%
2021-12-31HK$1.142 T-2.11%
2020-12-31HK$1.167 T68.18%
2019-12-31HK$694.03 B49.33%
2018-12-31HK$464.77 B-15.96%
2017-12-31HK$553.04 B7.9%
2016-12-31HK$512.56 B24.66%
2015-12-31HK$411.17 B92.67%
2014-12-31HK$213.40 B-5.75%
2013-12-31HK$226.41 B8.15%
2012-12-31HK$209.34 B38.07%
2011-12-31HK$151.61 B-7.82%
2010-12-31HK$164.47 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
HK$1.631 T 55.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$881.74 B-16.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$710.14 B-32.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$230.78 B-78.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$462.70 B-55.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$705.84 B-32.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$894.27 B-14.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$645.25 B-38.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$36.30 B-96.54%๐Ÿ‡บ๐Ÿ‡ธ USA